Analyst Research: ACADIA Pharmaceuticals Inc (ACAD.O)


ACAD.O on Consolidated Issue listed on NASDAQ Global Market

18.09USD
19 Jun 2013
Price Change (% chg)

$-0.34 (-1.84%)
Prev Close
$18.43
Open
$18.45
Day's High
$18.62
Day's Low
$17.75
Volume
2,583,018
Avg. Vol
4,692,027
52-wk High
$20.09
52-wk Low
$1.42

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ACADIA PHARMACEUTICALS, INC. (ACAD-O) 6:29am EDT Thomson Reuters Stock Report 11 25.00
Market Edge Equity Research Report 16 Jun 2013 Market Edge 4 10.00
ACADIA Pharmaceuticals 15 Jun 2013 S&P Capital IQ Quantitative Report 6 69.00
ACADIA PHARMACEUTICALS INC (ACAD) 12-months forecast 14 Jun 2013 Pechala's Reports 1 15.00
ACADIA Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 14 Jun 2013 Reuters Investment Profile 12 20.00
ValuEngine Detailed Valuation Report for ACAD 12 Jun 2013 ValuEngine, Inc. 11 127.00
TheStreet.com Ratings Stock Report For: ACADIA PHARMACEUTICALS INC (ACAD) 8 Jun 2013 TheStreet.com Ratings 5 10.00
 

People

Name Age Since Current Position

Leslie Iversen

 75 2000 Independent Chairman of the Board

Uli Hacksell

 62 2009 President, Chief Executive Officer, Director

Thomas Aasen

 52 2009 Chief Financial Officer, Chief Business Officer, Executive Vice President, Treasurer

Roger Mills

 55 2012 Executive Vice President - Development, Chief Medical Officer

Glenn Baity

 43 2004 Vice President, General Counsel, Secretary
» More People

ACADIA Pharmaceuticals Inc News

Search Stocks